| Gene symbol | CD70 | Synonyms | CD27-L, CD27L, CD27LG, LPFS3, TNFSF7, TNLG8A | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19p13.3 | dbXrefs | |
| Description | CD70 molecule | ||||
| GTO ID | GTC2417 |
| Trial ID | NCT04502446 |
| Disease | T-Cell Lymphoma |
| Altered gene | CD70 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CTX130 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory T or B Cell Malignancies (COBALT-LYM) |
| Year | 2020 |
| Country | United States |
| Company sponsor | CRISPR Therapeutics AG |
| Other ID(s) | CRSP-ONC-004 |
| Cohort 1 | |||||||||||
|
|||||||||||